UMIN-CTR Clinical Trial

Recruitment status Terminated
Unique ID issued by UMIN UMIN000012940
Receipt No. R000015138
Scientific Title Gene mutation analysis such as FGF signaling in gastrointesitinal cancer
Date of disclosure of the study information 2014/01/24
Last modified on 2022/08/01 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Gene mutation analysis such as FGF signaling in gastrointesitinal cancer
Acronym Gene mutation analysis such as FGF signaling in gastrointesitinal cancer
Scientific Title Gene mutation analysis such as FGF signaling in gastrointesitinal cancer
Scientific Title:Acronym Gene mutation analysis such as FGF signaling in gastrointesitinal cancer
Region
Japan

Condition
Condition Cancer of digestive organs
Classification by specialty
Medicine in general Gastroenterology Hepato-biliary-pancreatic medicine
Hematology and clinical oncology
Classification by malignancy Malignancy
Genomic information YES

Objectives
Narrative objectives1 To analyse gene mutation such as Fibroblast Growth Factor (FGF) signaling in cancer of digestive organs.
Basic objectives2 Others
Basic objectives -Others Analysisi of gene mutation and location in cancer of digestive organs.
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Incidence and location of gene mutation such as FGF-FGFR signaling in cancer of digestive organs.
Key secondary outcomes

Base
Study type Others,meta-analysis etc

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Patients with cancer in digestive organs (esophageal, gastric , biliary, pancreatic) whose paraffin-embedded samples by biopsy, endoscopic resection or surgery were obtained at St Marianna University School of Medicine Hospital .
Key exclusion criteria None
Target sample size 500

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name TAKAKO NAKAJIMA
Organization St. Marianna University School of Medicine
Division name Department of Clinical Oncology
Zip code
Address 2-16-1, Sugao, Miyamae-ku, Kawasaki, Kanagawa
TEL 0449778111
Email tnakajima@marianna-u.ac.jp

Public contact
Name of contact person
1st name
Middle name
Last name TAKAKO NAKAJIMA
Organization St. Marianna University School of Medicine
Division name Department of Clinical Oncology
Zip code
Address 2-16-1, Sugao, Miyamae-ku, Kawasaki, Kanagawa
TEL 0449778111
Homepage URL
Email tnakajima@marianna-u.ac.jp

Sponsor
Institute St. Marianna University School of Medicine
Institute
Department

Funding Source
Organization St. Marianna University School of Medicine
Organization
Division
Category of Funding Organization
Nationality of Funding Organization

Other related organizations
Co-sponsor Kinki University School of Medicine, Department of Genome Biology
Name of secondary funder(s) Kinki University School of Medicine, Department of Genome Biology

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2014 Year 01 Month 24 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Terminated
Date of protocol fixation
2013 Year 06 Month 11 Day
Date of IRB
2013 Year 10 Month 10 Day
Anticipated trial start date
2014 Year 01 Month 24 Day
Last follow-up date
2017 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information Gene mutation analysis:

1. Gene mutation of FGF-FGFR pathway
2. Any new candidates of biomarker

Management information
Registered date
2014 Year 01 Month 24 Day
Last modified on
2022 Year 08 Month 01 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000015138